Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Iowa for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Iowa only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Iowa (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Paul Boeke (NPI 1447544192)

Field	Value
Entity Type	Individual
Organization	Paul Boeke
Address	1195 Boyson Rd Ste 200
City	Hiawatha
State	IA
ZIP	52233
Taxonomy	Ophthalmology Physician
NPI Enumerated	May 30, 2011

Payer Source	Total Paid
Medicare	$7.1M
Medicaid	$0

Key Findings

PAUL BOEKE is a Medicare-focused ophthalmology physician with $7.1M in lifetime Medicare revenue and no Medicaid billing on file; his NPI was enumerated 2011-05-30 (~15 years ago), indicating an established practice tenure in the Medicare program. The absence of Medicaid claims makes his effective payer mix single-payer Medicare at scale, which is material for network access and reimbursement negotiations.

Revenue is highly concentrated in a narrow set of intravitreal drug and procedure codes: the precomputed top 3 Medicare codes (J0178, J2777, and 67028) account for 89.5% of this provider's total Medicare revenue. The single-code share of J0178 at 61.8% of Medicare revenue underscores that the practice’s financial performance is driven overwhelmingly by high-volume biologic injections.

The code mix and volumes indicate a retina-focused, procedure-driven service line rather than a general ophthalmology clinic: J0178 (injection, aflibercept) tallied 6.3K claims and $4.4M revenue, J2777 (faricimab) accounts for $1.6M, and 67028 (isolated intravitreal injection) contributes $345.6K. High utilization of 92134 (5.1K claims, $142.4K revenue) further supports a workload centered on retinal diagnostic imaging and ongoing intravitreal management.

This provider is a national outlier on several high-revenue codes: J0178 ranks #10 of 3204 providers nationally (100th percentile; extreme outlier, far above typical national volume for this code), 67028 ranks #24 of 4255 (99th percentile; extreme outlier), and 92134 ranks #44 of 26868 (100th percentile; extreme outlier). Those ranks indicate dominant national standing for aflibercept administration and high throughput for retinal imaging relative to peers.

J2777 (faricimab) performance is also notably elevated: it generated $1.6M in revenue and ranks #82 of 2039 providers nationally (96th percentile; notably above typical national volume for this code), signaling that the practice adopted newer intravitreal biologics at above-average volume relative to most peers. In contrast, biologic code J2778 (ranibizumab) shows typical volume and lower share ($309.4K, 4.4% of Medicare revenue), suggesting specific drug mix preferences.

Non-injection evaluation and management and general ophthalmology services comprise only a small portion of reported Medicare revenue: codes such as 92014 ($55.1K) and 99214 ($50.6K) each represent under 1% of Medicare revenue and rank at typical national percentiles. This pattern reinforces that the practice’s revenue model prioritizes high-volume procedural drug administration and retinal diagnostics rather than office-based E/M encounters.

The extreme concentration in drug administration codes creates both business leverage and exposure: with J0178 and J2777 among the top revenue drivers (and the top 3 codes accounting for 89.5% of Medicare revenue), the practice’s topline is sensitive to changes in drug pricing, formulary placement, reimbursement policy, and supplier availability for intravitreal biologics. Payors and contracting teams should treat shifts in these drug markets as key risk factors for this provider’s Medicare revenue.

Operationally, the alignment of very high-volume drug codes with a high-ranking procedural injection code (67028) and retinal imaging (92134) implies a throughput-oriented clinic workflow optimized for intravitreal therapy delivery and follow-up imaging. For payer analytics or competitive benchmarking, this provider should be categorized as a high-volume retina injector and imaging center with outsized national standing on specific biologic administration codes.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

22 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	6,340	$690	$4.4M
J2777	Injection, faricimab‑svoa, 0.1 mg	55,680	$30	$1.6M
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	4,070	$90	$345.6K
J2778	Injection, ranibizumab, 0.1 mg	1,720	$180	$309.4K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	5,090	$30	$142.4K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	710	$80	$55.1K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	600	$80	$50.6K
J3590	Unclassified biologics	410	$120	$48.7K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	740	$60	$42K
67042	In this procedure, the provider removes vitreous humor, the gelatinous material that gives shape to the eye, using a mechanical cutting tool. He removes the internal limiting membrane of the retina…	40	$820	$31.9K

Showing 1–10 of 22

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 22 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Iowa Distribution

Paul Boeke — 5 of 22 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Iowa

Full comparison — all codes billed, vs. state median

22 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J2777	11	20	43,140	$30	$1.7M
J0178	1	40	640	$690	$760.2K
J2778	5	20	780	$180	$259.9K
67028	3	60	420	$80	$80.6K
67042	6	20	20	$900	$28.8K
J3590	5	30	140	$100	$26.7K
92014	29	500	200	$70	$19.8K
67036	6	10	20	$740	$15.5K
67108	10	20	20	$830	$15K
99214	354	4,690	100	$70	$14.4K

Showing 1–10 of 22

Related Providers

Other providers that share a Tax Identification Number (TIN) with Paul Boeke, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Wolfe Clinic Inc	IA	Ophthalmology Physician	$0	$18.2M
Thomas Buroker	IA	Medical Oncology Physician	$9.4M	$0
Kyle Alliman	IA	Ophthalmology Physician	$8.7M	$0
Alex Kartvelishvili	IA	Ophthalmology Physician	$8.1M	$0
Austin Strohbehn	IA	Retina Specialist (Ophthalmology) Physician	$5.8M	$0
Jeremy Deutsch	KS	Hematology & Oncology Physician	$5.7M	$0
Robert Behrens	IA	Medical Oncology Physician	$5.2M	$0
Matthew Mcknight	IA	Foot & Ankle Surgery Podiatrist	$4.7M	$23.5K
James Singer	IA	Retina Specialist (Ophthalmology) Physician	$4.1M	$0
Christopher Haupert	IA	Retina Specialist (Ophthalmology) Physician	$3.9M	$0

Nearby Providers

Other providers in the same ZIP code as Paul Boeke, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Rem Iowa Community Services, Inc.	IA	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$155M
Rem Iowa Developmental Services, Inc.	IA	Developmentally Disabled Services Day Training Agency	$0	$18.1M
Mercy Surgery Center LLC	IA	Ambulatory Surgical Clinic/Center	$1.7M	$67.6K
Recover Health Of Iowa, Inc.	IA	Home Health Agency	$0	$932.3K
Edward Hu	IA	Ophthalmology Physician	$706.8K	$2.3K
Brian Dvorak	IA	Foot Surgery Podiatrist	$136.8K	$0
Caroline Wilson	IA	Ophthalmology Physician	$127.7K	$0
Timothy Sagers	IA	Family Medicine Physician	$126.7K	$0
Brian Ray	IA	Family Medicine Physician	$115.2K	$0
Todd Dolphin	IA	Podiatrist	$103.9K	$0

Paul Boeke — Billing Profile & Reimbursement Data

Sign up for Paul Boeke — Billing Profile & Reimbursement Data policy alerts

Paul Boeke — Billing Profile & Reimbursement Data

Sign up for Paul Boeke — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References